Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration

Addressing coronavirus disease 2019 (COVID-19) vaccine hesitancy and minimizing potential vaccine contraindications are critical to combatting the pandemic. We describe a practical approach to immediate adverse events after the first dose of messenger RNA vaccines for severe acute respiratory syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanijcharoenkarn, Kristine, Lee, Frances Eun-Hyung, Martin, Lindsay, Shih, Jennifer, Sexton, Mary Elizabeth, Kuruvilla, Merin Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194535/
https://www.ncbi.nlm.nih.gov/pubmed/33989390
http://dx.doi.org/10.1093/cid/ciab448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194535/
https://www.ncbi.nlm.nih.gov/pubmed/33989390
http://dx.doi.org/10.1093/cid/ciab448

Ejemplares similares